Relationship between Systemic Inflammatory Marker, Oxidative Stress and Body Mass Index in Stable COPD Patient

안정된 만성폐쇄성폐질환 환자에서 신체질량지수와 전신 염증인자, 산화 스트레스와의 관련성

  • Ham, Hyun Seok (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Lee, Hae Young (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Lee, Seung Jun (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Cho, Yu Ji (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Jeong, Yi Young (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Kim, Ho Cheol (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Ham, Jong Ryeal (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Park, Chan Hoo (Department of Pediatrics, College of Medicine, Gyeongsang National University) ;
  • Lee, Jong Deok (Department of Internal Medicine, College of Medicine, Gyeongsang National University) ;
  • Sohn, Hyun Joon (Department of Anatomy, Medical School of Chungbuk National University) ;
  • Youn, Hee Shang (Department of Pediatrics, College of Medicine, Gyeongsang National University) ;
  • Hwang, Young Sil (Department of Internal Medicine, College of Medicine, Gyeongsang National University)
  • 함현석 (경상대학교 의과대학 내과학교실) ;
  • 이해영 (경상대학교 의과대학 내과학교실) ;
  • 이승준 (경상대학교 의과대학 내과학교실) ;
  • 조유지 (경상대학교 의과대학 내과학교실) ;
  • 정이영 (경상대학교 의과대학 내과학교실) ;
  • 김호철 (경상대학교 의과대학 내과학교실) ;
  • 함종렬 (경상대학교 의과대학 내과학교실) ;
  • 박찬후 (경상대학교 의과대학 소아과학교실) ;
  • 이종덕 (경상대학교 의과대학 내과학교실) ;
  • 손현준 (충북대학교 의과대학 해부학교실) ;
  • 윤희상 (경상대학교 의과대학 소아과학교실) ;
  • 황영실 (경상대학교 의과대학 내과학교실)
  • Received : 2006.07.07
  • Accepted : 2006.09.15
  • Published : 2006.10.30

Abstract

Background: The main factors associated with weight loss in patients with COPD are not well known. Since chronic inflammation and oxidative stress play a major pathogenic role in COPD, these factors may be responsible for the patients' weight loss. Therefore, this study measured the body mass index (BMI) in COPD patients and evaluated the variables, such as systemic inflammatory marker, oxidative stress and lung function, that correlate with the BMI. Method: The stable COPD patients (M:F=49:4, mean age=$68.25{\pm}6.32$) were divided into the lower (<18.5), normal (18.5-25) and higher (>25) BMI group. The severity of the airway obstruction was evaluated by measuring the $FEV_1$. The serum IL-6 and TNF-$\alpha$ levels were measured to determine the degree of systemic inflammation, and the carbonyl protein and 8-iso-prostaglandin $F_2{\alpha}$ level was measured to determine the level of oxidative stress. Each value in the COPD patients and normal control was compared with the BMI. Results: 1) Serum 8-iso-prostaglandin $F_2{\alpha}$ in COPD patients was significantly higher ($456.08{\pm}574.12pg/ml$) than that in normal control ($264.74{\pm}143.15pg/ml$) (p<0.05). However, there were no significant differences in the serum IL-6, TNF-$\alpha$, carbonyl protein between the COPD patients and normal controls. 2). In the COPD patients, the $FEV_1$ of the lower BMI group was significantly lower ($0.93{\pm}0.25L$) than that of the normal BMI ($1.34{\pm}0.52L$) and higher BMI groups ($1.72{\pm}0.41L$) (p<0.05). The lower $FEV_1$ was significantly associated with a lower BMI in COPD patients (p=0.002, r=0.42). The BMI of very severe COPD patients was significantly lower ($19.8{\pm}2.57$) than that of the patients with moderate COPD ($22.6{\pm}3.14$) (p<0.05). 3). There were no significant differences in the serum IL-6, TNF-$\alpha$, carbonyl protein and 8-iso-prostaglandin $F_2{\alpha}$ according to the BMI in the COPD patients. Conclusion: The severity of the airway obstruction, not the systemic inflammatory markers and oxidative stress, might be associated with the BMI in stable COPD patients. Further study will be needed to determine the factors associated with the decrease in the BMI of COPD patients.

연구배경: 만성폐쇄성폐질환은 기도염증으로 인한 기도폐쇄를 특징으로 하는 질환이지만, 질병의 경과중에 체중감소나 근위축 같은 전신증상을 동반하게 된다. 만성 염증과 산화 스트레스가 만성폐쇄성폐질환의 병인에 중요한 역할을 하므로 신체질량지수의 감소와 관련이 있을 것으로 추측할 수 있다. 연구자 등은 안정된 만성폐쇄성폐질환 환자에서 신체질량지수와 관련된 인자를 알아보기 위해 다음과 같은 연구를 시행하였다. 방 법: 안정된 만성폐쇄성폐질환 환자 53명(남:여=49:4, 평균나이=$68.25{\pm}6.32$)과 정상 대조군 33명을 대상으로 폐기능 검사를 실시하고 전신염증인자로 혈청 IL-6, TNF-$\alpha$를 측정하고 산화 스트레스 인자로 혈청 8-iso-prostaglandin $F_2{\alpha}$와 carbonyl protein을 측정하여 비교하였다. 또한 만성폐쇄성폐질환 환자를 신체질량지수에 따라 다시 3군(<18.5, 18.5-25, >25)으로 나누어 각각의 수치들을 비교하였고 만성폐쇄성폐질환의 중증도에 따라 신체질량지수를 비교하였다. 결 과: 만성폐쇄성폐질환 환자와 정상 대조군의 혈청에서 IL-6, TNF-$\alpha$, carbonyl protein은 유의한 차이가 없었으며 8-iso-prostaglandin $F_2{\alpha}$은 각각 $456.08{\pm}574.12pg/ml$, $264.74{\pm}143.15pg/ml$로 만성폐쇄성폐질환 환자에서 유의하게 높았다(p<0.05). 만성폐쇄성폐질환에서 신체질량지수의 차이에 따라 혈청 IL-6, TNF-$\alpha$, carbonyl protein과 8-iso-prostaglandin $F_2{\alpha}$은 유의한 차이를 보이지 않았다. 신체질량지수에 따른 환자의 $FEV_1$은 각각 $0.93{\pm}0.25L$, $1.34{\pm}0.52L$, $1.72{\pm}0.41L$로 신체질량지수가 낮을수록 $FEV_1$ 값도 감소하는 경향을 보였고(p=0.002, r=0.42), 최중증 만성폐쇄성폐질환 환자의 신체질량지수는 $19.8{\pm}2.57$로 중등증의 환자의 $22.6{\pm}3.14$에 비해 유의하게 낮았다(p<0.05). 결 론: 본 연구에서 안정된 만성폐쇄성폐질환 환자의 신체질량지수는 전신염증인자와 산화 스트레스의 정도와는 관련을 보이지 않았으나 기도폐쇄의 정도와는 관련이 있을 것으로 사료된다. 만성폐쇄성폐질환 환자에서 신체질량지수의 감소와 관련된 인자에 대해서는 추가적인 연구가 필요할 것으로 사료된다.

Keywords

References

  1. Global Initiative for Chronic Obstructive Lung Disease. NHLBI/WHO, Workshop report. National Institutes of Health Publication Number 2701, 2001
  2. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005:2:258-66
  3. Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med 2005:26:142-53 https://doi.org/10.1055/s-2005-869535
  4. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005:2:50-60
  5. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003:21:347-60 https://doi.org/10.1183/09031936.03.00405703
  6. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J 2005:26:703-19 https://doi.org/10.1183/09031936.05.00139904
  7. Agust AG, Gari PG, Sauleda J, Busquets X. Weight loss in chronic obstructive pulmonary disease: mechanisms and implications. Pulm Pharmacol Ther 2002:15:425-32 https://doi.org/10.1006/pupt.2002.0385
  8. Dolan S, Varkey B. Prognostic factors in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2005:11:149-52 https://doi.org/10.1097/01.mcp.0000153548.36054.8f
  9. Celli BR, Cote CG, Martin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004:350:1005-12 https://doi.org/10.1056/NEJMoa021322
  10. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable COPD; eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993:147:1151-6 https://doi.org/10.1164/ajrccm/147.5.1151
  11. di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994:150:1453-5. https://doi.org/10.1164/ajrccm.150.5.7952575
  12. de Godoy I, Donahoe M, Calhoun WJ, Mancino J, Rogers RM. Elevated TNF-a production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 1996:153:633-7 https://doi.org/10.1164/ajrccm.153.2.8564110
  13. Song W, Zhao Z, Li Z. Interleukin-6 in bronchoalveolar lavage fluid from patients with COPD. Chin Med J 2001:114:1140-2.
  14. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor- with muscle mass and muscle strength in elderly men and women. J Gerontol A Biol Sci Med Sci 2002:57: M326-32 https://doi.org/10.1093/gerona/57.5.M326
  15. Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl 2003:41:46s-53s
  16. Expert Panel on the Identification, Evaluation and Treatment of Overweight in Adults. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Am J Clin Nutr 1998:68:899-917 https://doi.org/10.1093/ajcn/68.4.899
  17. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003:329:23-38 https://doi.org/10.1016/S0009-8981(03)00003-2
  18. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 2001:280:L1067-82
  19. Biernacki WA, Kharitonov SA, Barnes PJ. Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003:58:294-8 https://doi.org/10.1136/thorax.58.4.294
  20. PraticoD, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F 2a-III, an index of oxidant stress. Am J Respir Crit Care Med 1998:158:1709-14 https://doi.org/10.1164/ajrccm.158.6.9709066
  21. Wouters EF. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005:2:26-33
  22. Malo O, Sauleda J, Busquets X, Miralles C, Agusti AG, Noguera A. Systemic inflammation during exacerbations of chronic obstructive pulmonary disease. Arch Bronconeumol 2002:38:172- 6 https://doi.org/10.1016/S0300-2896(02)75184-3
  23. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor$\alpha$ system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000:161:1179-84 https://doi.org/10.1164/ajrccm.161.4.9903022
  24. Petrovsky N, Harrison LC. The chronobiology of human cytokine production. Int Rev Immunol 1998; 16:635-49 https://doi.org/10.3109/08830189809043012
  25. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med 2003:9:169-76 https://doi.org/10.1016/S1471-4914(03)00031-5
  26. Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005:171:1116-24 https://doi.org/10.1164/rccm.200407-887OC
  27. Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003:29:771-8 https://doi.org/10.1165/rcmb.2003-0138OC
  28. Karadag F, Karul AB, Cildag O, Altun C, Gurgey O. Determinants of BMI in patients with COPD. Respirology 2004:9:70-5 https://doi.org/10.1111/j.1440-1843.2003.00533.x